Tyrosine kinase inhibitors for chronic myeloid leukemia: a landscape analysis of global clinical trials based on public registries.

Zhang L, Tian Q, Tang Y, Liu H, Chen Y, Wen H, Liu J, Zhang X, Huang R, Luo Z, Geng T, Xie J.

Open source

DOI: 10.3389/fphar.2026.1904028
Published: 2026-09-07
Container: Front Pharmacol
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fphar.2026.1904028,
  title = {Tyrosine kinase inhibitors for chronic myeloid leukemia: a landscape analysis of global clinical trials based on public registries.},
  author = {Zhang L and  Tian Q and  Tang Y and  Liu H and  Chen Y and  Wen H and  Liu J and  Zhang X and  Huang R and  Luo Z and  Geng T and  Xie J.},
  year = {2026},
  journal = {Front Pharmacol},
  doi = {10.3389/fphar.2026.1904028},
  url = {https://doi.org/10.3389/fphar.2026.1904028}
}

RIS

TY  - JOUR
TI  - Tyrosine kinase inhibitors for chronic myeloid leukemia: a landscape analysis of global clinical trials based on public registries.
AU  - Zhang L
AU  -  Tian Q
AU  -  Tang Y
AU  -  Liu H
AU  -  Chen Y
AU  -  Wen H
AU  -  Liu J
AU  -  Zhang X
AU  -  Huang R
AU  -  Luo Z
AU  -  Geng T
AU  -  Xie J.
PY  - 2026
JO  - Front Pharmacol
DO  - 10.3389/fphar.2026.1904028
UR  - https://doi.org/10.3389/fphar.2026.1904028
ER  -

APA

L, Z., Q, T., Y, T., H, L., Y, C., H, W., J, L., X, Z., R, H., Z, L., T, G., & J., X. (2026). Tyrosine kinase inhibitors for chronic myeloid leukemia: a landscape analysis of global clinical trials based on public registries.. Front Pharmacol. https://doi.org/10.3389/fphar.2026.1904028

Source records

europe-pmc · retrieved 2026-09-25T11:03:44.061Z
doaj · retrieved 2026-09-25T11:03:44.053Z